Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FDAHU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $162,473
Award facts
- Contract value 100% obligated
- $162,473.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $162,473.40 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pens on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in federal medical procurement through its extensive portfolio of delivery orders with the Defense Logistics Agency and Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support defense and veteran healthcare systems. This specific award for Wegovy, a GLP-1 receptor agonist medication used in diabetes and weight management treatment, reflects the company's role in delivering critical pharmaceutical commodities to the Defense Health Agency and related federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB25FDAHU?
SPE2DB25FDAHU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FDAHU worth?
The government has obligated $162,473 on SPE2DB25FDAHU.
Is contract SPE2DB25FDAHU an order under another contract?
Yes. SPE2DB25FDAHU is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDAHU competed?
The extent of competition for SPE2DB25FDAHU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award